Cyclerion Therapeutics (CYCN) Receivables - Other (2019 - 2020)

Cyclerion Therapeutics (CYCN) recorded quarterly Receivables - Other of $127000.0 in Q4 2020, down 68.25% quarter-over-quarter from $400000.0 in Q3 2020, and down 91.53% on a YoY basis from $1.5 million in Q1 2020.

Cyclerion Therapeutics (CYCN) Receivables - Other (2019 - 2020) Analysis & Trends

Cyclerion Therapeutics' Receivables - Other history runs 2 years deep, the most recent figure standing at $127000.0 for Q4 2020.

  • In Q4 2020, Receivables - Other fell 91.53% year-over-year to $127000.0; the TTM figure through Dec 2020 stood at $127000.0 (down 91.53% YoY), while the FY2020 annual figure was $100000.0, down 93.33% from the prior year.
  • Receivables - Other was $127000.0 for Q4 2020 at Cyclerion Therapeutics, down from $400000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.6 million in Q2 2019 to a low of $127000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Cyclerion Therapeutics 11.50 Mn 8.26 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 127,000.00
Dec 31, 2020 127,000.00
Sep 30, 2020 400,000.00
Sep 30, 2020 400,000.00
Jun 30, 2020 751,000.00
Jun 30, 2020 751,000.00
Mar 31, 2020 1.00 Mn
Mar 31, 2020 1.00 Mn
Dec 31, 2019 1.50 Mn
Dec 31, 2019 1.50 Mn
Sep 30, 2019 1.40 Mn
Sep 30, 2019 1.40 Mn
Jun 30, 2019 1.60 Mn
Jun 30, 2019 1.60 Mn